Associated Papers
Understanding how transmembrane domains regulate interactions between human BST-2 and the SARS-CoV-2 accessory protein ORF7a.
Mann MM et al.
Biochimica Et Biophysica Acta. Biomembranes, 2023
In Silico Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts.
Sneha P et al.
Medical Sciences (basel, Switzerland), 2019
HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions.
Skasko M et al.
The Journal of Biological Chemistry, 2012
Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility.
Kobayashi T et al.
Journal of Virology, 2011
Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
Vigan R et al.
Journal of Virology, 2010
The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.
Pardieu C et al.
Plos Pathogens, 2010
Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.
McNatt MW et al.
Plos Pathogens, 2009
Select a paper to view details